A Study to Evaluate Endoscope-assisted, Minimally-invasive Cortical Access System for Chronic Subdural Evacuation
Not Applicable
Terminated
- Conditions
- Chronic Subdural Hematoma
- Interventions
- Device: Minimally Invasive Cortical Access System (MICAS)
- Registration Number
- NCT04502745
- Lead Sponsor
- Mayo Clinic
- Brief Summary
The purpose of this study is to evaluate a less-invasive alternative to the currently available method of removing aging blood in the subdural space.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- 6
Inclusion Criteria
- Must be 55 years of age or greater.
- Have a clinically symptomatic chronic subdural hematoma greater than 1 cm in maximal thickness and be judged clinically to need subdural evacuation.
Read More
Exclusion Criteria
- Failure to obtain consent.
- Vulnerable study population.
- Any need for chronic anticoagulation.
- Pregnancy (verified by pregnancy testing at screening or medical history of a hysterectomy, oophorectomy, or post-menopausal).Prior surgery for subdural hematoma.
- Glasgow Coma Scale (GCS) less than 8.
Read More
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Treatment Group Minimally Invasive Cortical Access System (MICAS) During clinically indicated surgery for subdural hematoma, the patient will undergo a single burr hole evacuation with the MICAS device with endoscopic assistance.
- Primary Outcome Measures
Name Time Method Incidence of all serious adverse events 3 years Number of adverse events including unanticipated adverse device effects
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Mayo Clinic in Rochester
🇺🇸Rochester, Minnesota, United States